EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 4.0

Cardiovascular Autonomic Dysfunction in Cancer Therapy: Clinical Manifestations and Management

Tyler Abram Kilgore iD, Sruthi Vellanki, Sravya Vellanki, Jeffrey Curran Henson, Srikanth Vallurupalli

Cardiology Research · 2026-08 · 17 (4) · 267-276

DOI: 10.14740/cr2242 ↗

At a glance

Übersichtsarbeit in Cardiology Research, 2026-08. Written by Tyler Abram Kilgore and 4 co-authors. Institution: Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Cardiovascular autonomic dysfunction is an underrecognized manifestation of cancer therapy–related cardiotoxicity with important clinical implications. Disruption of autonomic regulation during chemotherapy most commonly manifests as orthostatic hypotension, inappropriate sinus tachycardia, and reduced heart rate variability, often occurring in the absence of overt structural heart disease. These abnormalities may contribute to symptom burden, impaired functional capacity, and increased cardiovascular risk in patients undergoing cancer treatment. Emerging data indicate that autonomic dysfunction in this setting may be modifiable. Among available interventions, structured exercise programs demonstrate the strongest and most consistent improvements in autonomic indices, alongside established benefits in functional capacity, fatigue, and quality of life. Relaxation and mindfulness-based interventions, including yoga, offer low-risk adjunctive benefits, whereas cryotherapy remains exploratory. Pharmacologic therapies play a symptom-directed role, particularly for orthostatic hypotension, but are often constrained by comorbid cardiovascular disease and limited oncology-specific evidence. This review evaluates current evidence on the clinical manifestations and therapeutic strategies for chemotherapy-associated cardiovascular autonomic dysfunction, highlighting opportunities to improve patient-centered outcomes in cardio-oncology care.

Subjects

Author keywords

Cardio-oncologyCardiovascular autonomic dysfunctionExerciseHeart rate variabilityMindfulnessOrthostatic hypotensionSinus tachycardiaYoga

Authors and institutions

  • Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Division of Hematology and Medical Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Department of Internal Medicine, Willis Knighton Health, Shreveport, LA, USA.
  • Division of Cardiology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

ORCID profiles: Tyler Abram Kilgore

Cite

APA

Kilgore, T. A., Vellanki, S., Vellanki, S., Henson, J. C., & Vallurupalli, S. (2026). Cardiovascular Autonomic Dysfunction in Cancer Therapy: Clinical Manifestations and Management. Cardiology Research, 17(4), 267-276. https://doi.org/10.14740/cr2242

Vancouver

Kilgore TA, Vellanki S, Vellanki S, Henson JC, Vallurupalli S. Cardiovascular Autonomic Dysfunction in Cancer Therapy: Clinical Manifestations and Management. Cardiology Research. 2026;17(4):267-276. doi:10.14740/cr2242

BibTeX
@article{Kilgore2026,
  author = {Kilgore, Tyler Abram and Vellanki, Sruthi and Vellanki, Sravya and Henson, Jeffrey Curran and Vallurupalli, Srikanth},
  title = {Cardiovascular Autonomic Dysfunction in Cancer Therapy: Clinical Manifestations and Management},
  journal = {Cardiology Research},
  year = {2026},
  volume = {17},
  number = {4},
  pages = {267--276},
  doi = {10.14740/cr2242}
}
Start for free →